The theme of this third edition will be “Enhancing Predictivity in Medicines Development” and will focus on bringing together the latest approaches to increase chances of success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification. The conference will start on Sunday, September 24 with a series of educational workshops. The workshops will be dedicated to key topics in the field such as molecular imaging, biomarker validation and potency assays for ATMP. The plenary session on September 25 & 26 will be structured around three subthemes:
Session 1: The Funder, Developer and Regulator as Partners in Innovation
Session 2: Novel approaches in clinical development
Session 3: Developing more predictive preclinical tools to better reach proof of concept
